clonazepam has been researched along with Kidney Diseases in 5 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide is one of the most efficient antimitotic in soft tissue sarcoma." | 5.08 | [High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients]. ( Baranzelli, MC; Deligny, N; Demaille, MC; Gourmel, B; N'Guyen, M; Pichon, F, 1997) |
| "Anticonvulsant therapy was among the first areas to benefit from clinical pharmacokinetic studies." | 2.35 | Clinical pharmacokinetics of anticonvulsants. ( Dam, M; Hvidberg, EF, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranzelli, MC | 1 |
| Pichon, F | 1 |
| Gourmel, B | 1 |
| N'Guyen, M | 1 |
| Deligny, N | 1 |
| Demaille, MC | 1 |
| Hvidberg, EF | 1 |
| Dam, M | 1 |
| Larsen, M | 1 |
| Larsen, S | 1 |
| Lorenzen, I | 1 |
| Amiel, M | 1 |
| Bryan, S | 1 |
| Herjanic, M | 1 |
| Pacifici, GM | 1 |
| Viani, A | 1 |
| Rizzo, G | 1 |
| Carrai, M | 1 |
| Rane, A | 1 |
1 review available for clonazepam and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of anticonvulsants.
Topics: Administration, Oral; Adult; Aged; Aging; Animals; Anticonvulsants; Carbamazepine; Child; Clonazepam | 1976 |
1 trial available for clonazepam and Kidney Diseases
| Article | Year |
|---|---|
[High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients].
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Clonazepam; Dose-Response Relations | 1997 |
3 other studies available for clonazepam and Kidney Diseases
| Article | Year |
|---|---|
[Sequential statistical analysis. New applications in clinical problems].
Topics: Azathioprine; Clonazepam; Cyclophosphamide; Duodenal Ulcer; Epilepsy; Humans; Kidney Diseases; Stati | 1975 |
Clonazepam in the treatment of bipolar disorder in patients with non-lithium-induced renal insufficiency.
Topics: Bipolar Disorder; Clonazepam; Female; Humans; Kidney Diseases; Lithium; Lithium Carbonate; Middle Ag | 1987 |
Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis.
Topics: Adult; Aged; Blood Proteins; Clonazepam; Fatty Acids, Nonesterified; Female; Humans; Kidney Diseases | 1987 |